Next Article in Journal
Impaired Vitamin D Metabolism in Hospitalized COVID-19 Patients
Next Article in Special Issue
The Role of Myrrh Metabolites in Cancer, Inflammation, and Wound Healing: Prospects for a Multi-Targeted Drug Therapy
Previous Article in Journal
Siccanin Is a Dual-Target Inhibitor of Plasmodium falciparum Mitochondrial Complex II and Complex III
Previous Article in Special Issue
Short-Term Administration of Lemon Balm Extract Ameliorates Myocardial Ischemia/Reperfusion Injury: Focus on Oxidative Stress
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Traditional Uses, Phytochemistry, and Pharmacological Properties of the Genus Blechnum—A Narrative Review

by
Emmanuel Nyongesa Waswa
1,2,3,4,
Felix Wambua Muema
1,2,3,4,
Wyclif Ochieng Odago
1,2,3,4,
Elizabeth Syowai Mutinda
1,2,3,4,
Consolata Nanjala
1,2,3,4,
Elijah Mbandi Mkala
1,2,3,4,
Sarah Getachew Amenu
1,2,3,4,
Shi-Xiong Ding
1,2,3,4,
Jing Li
1,2,3,4 and
Guang-Wan Hu
1,2,3,4,*
1
Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture, Wuhan Botanical Garden, Chinese Academy of Sciences, Wuhan 430074, China
2
Center of Conservation Biology, Department of Botany, Core Botanical Gardens/Wuhan Botanical Garden, Chinese Academy of Sciences, Wuhan 430074, China
3
Sino-Africa Joint Research Center, Chinese Academy of Sciences, Wuhan 430074, China
4
University of Chinese Academy of Sciences, Beijing 100049, China
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2022, 15(7), 905; https://doi.org/10.3390/ph15070905
Submission received: 28 June 2022 / Revised: 15 July 2022 / Accepted: 15 July 2022 / Published: 21 July 2022

Abstract

:
Blechnum L. is a genus belonging to the Blechnaceae family with 236 accepted species that grow in intertropical, subtropical, and southern temperate regions. Several species of the genus have long been used in folk medicines to treat a broad spectrum of ailments, including typhoid, urinary infections, influenza, wounds, pulmonary complaints, blisters, boils, and antihelmintic-related complications. So far, about 91 chemical compounds have been isolated from different parts of 20 Blechnum species. Among these metabolites, phenolic compounds, sterols, and fatty acids are the main constituents. Modern pharmacological investigations revealed several isolated compounds and extracts to exhibit exceptional biological properties including the antioxidant, antimicrobial, anti-inflammatory, anticancer, insecticidal, antitrematocidal and wound healing. In various tests, both quercetin-7′,3′,4′-trimethoxy and phytol metabolites showed potential antioxidant and antitrematocidal properties, while ponasterone exhibited insecticidal activity. Despite having a broad range of traditional medicinal benefits and biological properties, understanding the scientific connotations based on the available data is still challenging. This article presents a comprehensive review of the traditional uses, phytochemical compounds, and pharmacological aspects of the Blechnum species.

Graphical Abstract

1. Introduction

Ancient traditional knowledge of plants’ medicinal utility contributes significantly to bioprospecting by identifying plants for drug discovery. Many medicinal plants are effective remedies for diverse complaints, prompting increased screening for their therapeutic constituents [1,2]. In the past, pteridophytes (fern and fern-allies) were considered as significant sources of treatment against different disorders and for culinary purposes [3,4,5].
Blechnum L. (Blechnaceae) is a fern genus with approximately 236 species (https://powo.science.kew.org/, accessed on 7 April 2022) [6]. They are widespread in tropical regions [7] and encompass terrestrial, rupestral, climbing, or epiphytic plants. The species of this genus are referred to as hard or midsorus ferns. Several Blechnum species are used as herbal medicines to cure sicknesses such as pulmonary complaints, typhoid, influenza, urinary bladder, intestinal worms, wounds, blisters, and boils [1,8,9].
Natural agents with medicinal values have been extensively investigated in plants [10], and various studies have explored the phytocompounds and bioactivities of different Blechnum species. Blechnum is a novel source of alcohols, aldehydes, carotenoids, phenolic acids, sesquiterpene [11], fatty acids [12], phytosterols [13], steroids [14], lignans [15], flavonols, flavones [2,16], anthocyanidins [17], and diterpenes [18]. Blechnum species have been examined for pharmacological properties such as antioxidant [12], antimicrobial [19], anticancer [20], insecticidal [21], wound healing [22], antitrematocidal [23], and anti-inflammation [5]. A comprehensive description of the biological activities exhibited by the Blechnum species is expounded in the pharmacology section.
Even though several Blechnum species are globally employed in folk medicines, secondary metabolites and their biological activities have not been extensively investigated. Thus, the scientific basis for their traditional medicinal applications is poorly understood. The present article discusses the traditional uses, phytochemistry, and biological activities of the Blechnum species.
In this review, the scientific data was retrieved from published articles using various electronic search engines like PubMed, Web of Science, and Google Scholar. The searchers were not restricted to the quality of publication or language used. The Global Biodiversity Information Facility (GBIF) (https://www.gbif.org/, accessed on 7 April 2022), Flora of China (http://www.efloras.org, accessed on 7 May 2022), Plants of the World Online (POWO) (https://powo.science.kew.org/, accessed on 7 April 2022), and the International Union for Conservation of Nature (IUCN) (https://www.iucnredlist.org/, accessed on 18 April 2022) were used to gather information on the botanical description, distribution, and conservation status of Blechnum plants. The keywords used include Blechnum, distribution, physical characteristics, conservation, phytochemical compounds, biological activities, and traditional medicinal uses. The scientific names were confirmed using the World Flora online and Plants of the World Online (POWO) (https://powo.science.kew.org/, accessed on 4 May 2022) databases, while phytochemical structures were drawn using ChemBioDraw Ultra v14.0 software. Ninety-six articles were included in this study.

1.1. Botanical and Taxonomic Description

Blechnum species are distinguished by erect rhizomes which occasionally creep/form short trunks. The rhizomes consist of unarticulated stipes covered with protective hairlike scales, and in most Blechnum, they tend to exist primarily as underground structures. Leathery fronds are monomorphic or dimorphic [7], while circinate venation, simple lamina, and sometimes 1-pinnatifid or 1-pinnate characterize their stalks and leaf blades (Figure 1). The sterile and fertile fronds can either be pinnate or bipinnate (http://www.worldfloraonline.org, accessed on 11 April 2022). Rachis and costae are scaly and glabrous, whereas sori are paralleled next to costae and are borne on vascular commissures. They reproduce with spores as substitutes for seeds produced in bundles under the fronds. The spores are perine smooth to diversely winged or rugose, with reticulate perispore, and contain small papillae [7].
The genus Blechnum is found in the Blechnaceae family, subfamily Blechnoideae, and order Polypodiales. It is a taxonomically complex paraphyletic genus with unclear internal relationships. As presently conceived, this genus encompasses the variously formerly segregated genera including Spicanta C. Presl, Lomaridium C. Presl, Lomaria Willd., Blechnopsis C. Presl, Struthiopteris Scop., and Distaxia C. Presl [24]. It comprises approximately 236 globally accepted species and 29 synonyms (https://powo.science.kew.org/, accessed on 11 April 2022). In addition, two accepted subspecies and three varieties were described (http://www.worldfloraonline.org, accessed on 11 April 2022).

1.2. Distribution and Conservation Status

Blechnum species are broadly distributed in various parts of America, Europe, Africa, Australia, Asia, and several islands, including Hawaii, Mascarene, and Cunha among others (https://powo.science.kew.org/, accessed on 7 April 2022) [25] (Figure 2). They mainly occupy terrestrial, rocky areas and can exist as erect, climbing, or rarely epiphytic plants. In New Zealand, they are represented by about 18 indigenous species. In China, the Blechnum orientale (L.) C. Presl., is widespread in Fujian, Guangdong, Hainan, Hunan, Sichuan, Yunnan, Zhejiang, and neighboring areas (http://www.efloras.org, accessed on 7 April 2022). Additionally, 15 primarily epiphytic and terrestrial Blechnum plants are widespread in Mexico [7], whereas 13 are common in Chile [26]. Most of these species are sub-cosmopolitan and inhabit the intertropical, subtropical, and southern temperate regions. The conservation status of about 145 recognized Blechnum species are yet to be evaluated (https://www.iucnredlist.org/, accessed on 18 April 2022). Several species, including Blechnum attenuatum (Sw.) Mett., B. punctulatum Sw., B. australe L., and B. heringeri Brade. are listed as Least Concern (LC). In addition, B. eburneum Christ., B. monomorphum R.C. Moran & B. Øllg, and B. occidentale L., (B. sodiroi C. Chr) are reported as Vulnerable (VU), whereas B. floresii (Sodiro) C. Chr., is Endangered (EN).

2. Traditional Uses of Blechnum Species

Blechnum species are used in Chilean Traditional Medicines (CTM), Traditional Indian Medicines (TIMs), and Traditional Chinese Medicines (TCMs) for various medicinal folklore [26,27,28]. The different types of Blechnum-derived formulations in the form of decoction, poultice, infusion, paste, and juice (Table 1) prepared from the fronds, rhizomes, whole plants, roots, and shoots are remedies for cancer, typhoid, influenza, inflammation, female sterilization, liver infections, intestinal wounds, stomach complaints, pulmonary illnesses, skin disorders, and urinary bladder complaints (Figure 3, Table 1). Blechnum occidentale L., B. spicant (L.) Roth, B. serrulatum Rich, and B. orientale L. were found to be the most commonly utilized Blechnum species for medicinal purposes (Table 1).
Utilization of plants for medicinal purposes is attributed by their rich active ingredients [29]. They are utilized for clinical drug development as alternative natural agents to conventional chemotherapies. Traditional knowledge indicates that different parts of the Blechnum plants (Figure 4) possess medicinal efficacy towards diverse sicknesses, thereby contributing to human health. Blechnum orientale was established as the most commonly used species to prepare folk medicines in the studied genus. The frequently used parts in the preparation of herbal medicines included fronds and rhizomes, while roots and shoots are less widely used (Figure 4).
The fronds obtained from B. orientale are regarded as cure for intestinal wounds, pulmonary complaints, skin disorders, and urinary bladder infections. Additionally, those obtained from B. spicant are chewed to cure skin disorders, cancer, pulmonary, and stomach complaints, while B. serrulatum is used as a remedy for skin disorders. The rhizomes from B. orientale and B. serrulatum are also significant sources of traditional therapies for urinary bladder infections, typhoid, and intestinal worms (Table 1). Decoction prepared from the roots of B. spicant is used to cure diarrhoea, while the shoots obtained from B. orientale are pounded and the paste is applied to treat boils [30,31]. Oral ingestion of the entire plant of B. orientale has a medicinal relevance in the sterilization of women. Likewise, the whole plants of B. spicant are popular medicines against skin ailments in the United States of America [32].
Table 1. Traditional medicinal uses of the Blechnum species.
Table 1. Traditional medicinal uses of the Blechnum species.
Accepted SpeciesRegionParts UsedMedicinal UseReferences
B. spicant (L.) Roth. FrondsThe leaflets are chewed to treat internal cancer, lungs, and stomach complaints. [30]
They are externally applied to treat skin sores.[30]
Roots Decoctions prepared from the roots are used as a remedy for diarrhea[30]
United States of AmericaWhole plantTreatment of skin ailments [32]
B. orientale (L.) C. Presl.Malaysia.ShootsThe shoots are pounded and used as a paste to cure boils [31]
FrondsThe fronds are ground in cow’s milk to treat asthma[1]
Applied in the form of a poultice to treat boils[31]
Externally applied to cure blisters, boils, carbuncles, and sores
The leaves are crushed and applied as medication for abscesses [31,32,33]
IndiaFrondsUrinary bladder complaints[8,34]
Hot decoction prepared from pinnae is used for its antiseptic action or applied externally over a boil to release pus.[35]
The extracted juice is used to treat intestinal
Wounds.
[36]
RhizomesIt is orally administered to treat typhoid.[9,32]
The prepared paste is applied to cure urinary bladder infections.[36]
PhilippinesFrondsThey are used for polynesia,
diaphoretic, and operative actions
[8,28]
ChinaRhizomesAre used as an anthelminthic to cure intestinal worms[8,28]
Papua
New Guinea
Whole plantOrally ingested for women’s sterilization[32]
United States of America Treatment of influenza [37]
B. occidentale L. Brazil-The whole plant is frequently used as a therapy for pulmonary ailments, urinary disorders and liver infections.[3,38,39]
--Inflammation[40]
B. serrulatum Rich.French GuianaRhizomeAn infusion prepared from the rhizomes is used as a vermifuge.[41]
GuyanaFrondsUsed to treat abscesses [41]

3. Secondary Metabolites

Early phytochemical study of the Blechnum genus occurred in the 1960s, which revealed the existence of chlorogenic and blechnic acid in the leaves of B. spicant, B. orientale, B. discolor, and B. brasiliense [42]. Later, preliminary phytochemical studies identified numerous anthocyanidins from the leaves of B. procerum [17]. Other investigations in subsequent years resulted in isolation and identification of steroids, flavonols, flavones, lignans, fatty acids, phytosterols, diterpenes, sesquiterpenes, alcohols, aldehydes, carotenoids, and heterocyclic compounds (Figure 5).
In the present study, a detailed investigation of phytochemicals derived from the Blechnum species revealed a broad spectrum of structurally diverse and biologically active metabolites. Ninety-one specialized metabolites encompassing 39 phenolic compounds, 25 sterols, 12 fatty acids, 5 terpenes, 4 alcohols, 3 aldehydes, 2 carotenoids, and a heterocyclic compound were isolated (Table 2). The dominant specialized products were steroids, anthocyanidins, flavonoids, and fatty acids, whereas carotenoids, sesquiterpenes, and heterocyclic metabolites were the least isolated. Chemical compounds were primarily screened from leaves/fronds, rhizomes, whole plants, and aerial parts and are described based on the original sources. The major techniques used screen metabolites included Liquid Chromatography, Mass spectrometry (MS) and Nuclear Magnetic Resonance (NMR).

3.1. Phenolic Compounds

Phenolic compounds are among plants main classes of natural bioactive metabolites and are structurally distinguished by a single phenol unit, broadly grouped as simple phenols and polyphenols [43]. These metabolites were isolated from several Blechnum species, and 40 secondary metabolites are reported (Table 2), with some of their chemical structures depicted in Figure 6.

3.1.1. Simple Phenols/Phenol Derivatives

Numerous Blechnum species were reported as essential sources of rosmarinic and chlorogenic acid constituents [42,44,45]. The above-investigated compounds were found in the extracts prepared from the leaves of B. binervatum, B. brasiliense, B. orientale, B. discolor, B. brasiliense, B. spicant, and B. occidentale (compounds 1 and 2) (Table 2). Ethyl vanillate (3) metabolite was also detected from the aerial parts of B. spicant [11]. Rosmarinic acid (RA) screened from various medicinal plants has interesting health-promoting effects including antioxidant, anti-inflammatory, and antimicrobial properties [46,47,48]. In addition, numerous studies indicate that chlorogenic acid exhibits promising pharmacological properties [49,50,51].

3.1.2. Lignans

Lignans phytochemicals have been highly screened in various Blechnaceae species [52]. In the Blechnum genus, these compounds (47) were isolated from the fronds of B. orientale and B. spicant (Table 2). The investigation by Wada et al. [15] assessed B. orientale extracts and detected various metabolites including blechnic acid, 7-epiblechnic acid, 8-epiblechnic acid, and brainic acid. Figure 6 shows the chemical structures of some of the isolated lignans.

3.1.3. Polyphenols

Flavonols

Flavonoid compounds, a broad group of polyphenols with the C15-carbon skeleton, are highly distributed in plants and are linked with extensive health benefits such as antimicrobial, antiparasitic, anti-inflammation, and anticancer [53]. Several flavonol metabolites, primarily quercetin derivatives (815) and kaempferol derivatives (1619), were detected from the leaves and aerial parts of B. novae-zelandiae and B. orientale (Table 2).

Flavones

Flavones are structurally comprised of 2-phenyl-1,4-benzopyrone backbones, and their occurrence has been investigated in the studied genus. Several studies have reported flavones in B. orientale extracts [2,16,23]. Seven flavones (2026) constituting the luteolin (luteolin-7-glucuronide (20) and lucenin-2 (21)) and apigenin derivatives (2226) were screened and identified from the aerial parts of B. orientale (Table 2).

Anthocyanins

Anthocyanins are naturally-pigmented, water-soluble, bioactive flavonoid compounds [54]. The sugar-free analogues of anthocyanins are anthocyanidins. Approximately seven anthocyanidins metabolites were detected from the extracts of B. procerum and B. novae-zelandiae (2739) [17,55]. Anthocyanidins are brightly coloured anthocyanin-like pigments distinguished from C-3 oxygenated flavonoids by two doublets of heterocycle at the H-3 and H-4 positions. The 3-deocyanthocyanins metabolites consisting of apigeninidin (2732) and luteolinidin (3339) derivative groups were screened from the fronds of B. procerum and B. novae-zelandiae (Table 2).

3.2. Terpenoids

Terpenic compounds are amongst the widely isolated groups of phytochemicals in the Blechnaceae family [23,26]. The number of known screened terpenes in the Blechnum genus is relatively high compared to other specialized metabolites. Approximately five terpenes (compounds 4044) were isolated (Table 2), and some of their chemical structures are illustrated (Figure 7). The aerial parts of B. spicant contain (E)-nerolidol sesquiterpene (compound 40) [11]. This metabolite possesses several biological activities, including anticancer, antioxidant, and antimicrobial [56,57,58] effects. Furthermore, several diterpenes (4144) were isolated from the leaves and aerial parts of various Blechnum plants.

3.3. Sterols

Sterol metabolites have been highly isolated and identified in the family Blechnaceae [12,13,18]. They are isoprenoid derivatives with diverse composition existing as either free forms, conjugated, or steryl glycosides [59]. Sterol compounds with high structural diversity were isolated from numerous Blechnum plants (compounds 4569) (Table 2), and some of their structural diversity is represented in Figure 8. The phytoecdysteroids (compounds 4556): fundamental analogues in insects as moulting hormones were isolated from the fronds of B. vulcanicum [14]. Similarly, several other constituents including ecdysone (45), ponasterone (56), and shidasterone (57), were also screened from dried leaves of different Blechnum species. Compound (56) and its synthesized derivatives exhibited receptor-binding activities towards the ecdysone receptor of Kc cells [60].
The phytosterol compounds were also isolated from the whole plant extracts of B. orientale [12,13,18]. These are plant-derived fatty compounds with limited structural diversity and are cholesterol-related [10]. Numerous previous investigations reported the biological properties of the phytosterols, and nine compounds (6669) were isolated and identified primarily from the extracts of B. corralense, B. chilense, B. brasiliense, B. microphyllum. asperum, B. binervatum, B. mochaenum. blechnoides, B. hastatum, and B. penna-marina, B. magellanicum, B. arcuatum, and B. occidentale (Table 2).

3.4. Fatty Acids

Fatty acids encompass saturated and unsaturated hydrocarbon chains of variable sizes, distinguished by the carboxyl group positioned at one end, and the methyl group at the inverse [61]. Numerous studies have reported several fatty acids from plants to be linked to various biological properties [62,63]. In the present investigation, 12 structurally diverse fatty acid constituents (compounds 7081) were isolated from the leaves and whole plants of different Blechnum plants [11,12,23], and their representative chemical structures shown (Figure 9, Table 2). The phytochemical analysis by Maria et al. [12] revealed several fatty acid components (7078) from dichloromethane and hexane fractions prepared from the leaves of B. binervatum, B. occidentale, and B. brasiliense. Similarly, two fatty acid components; 1,2,3-propanetricarboxylic acid 2-hydroxy-, triethyl ester (79), and hexanedioic acid, mono (2-ethylhexyl) ester (80) were isolated from B. orientale extracts and registered to exhibit numerous medicinal properties including antimicrobial, anti-inflammatory, antioxidant, antiulcer, and nematicidal [23].
Table 2. Screened secondary metabolites from the Blechnum species.
Table 2. Screened secondary metabolites from the Blechnum species.
No.Secondary MetaboliteSpecimenPart UsedIdentification MethodReferences
Phenolic compounds
(a). Phenolic acids
1.Chlorogenic acidB. binervatum (Poir.) C.V.Morton & Lellinger,
B. brasiliense Desv,
B. orientale L.,
B. discolor (Forst.) Keyserl,
B. brasiliense Desv.,
B. spicant (L.) Roth, and
B. occidentale L.
FrondsTLC, HPLC-DAD-MS[42,44]
2.Rosmarinic acidB. binervatum (Poir.) C.V.Morton & Lellinger,
B. brasiliense Desv., and
B. occidentale L.
FrondsTLC, HPLC-DAD-MS[42,44,45]
3.Ethyl vanillateB. spicant (L.) RothAerial partsGC-MS[11]
(b). Lignans
4.Blechnic acidB. spicant (L.) Roth, and
B. orientale L.
FrondsTLC[15,42]
5.7-Epiblechnic acidB. orientale L.Fronds [15]
6.8-Epiblechnic acidB. orientale L.Fronds [15]
7.Brainic acidB. orientale L.Fronds [15]
(c). Flavonols
8.Quercetin-3,7-digalactosideB. orientale L.FrondsTLC[2,16]
9.Quercetin-7,4′-digalactosideB. orientale L.FrondsTLC[2,16]
10.Quercetin-3,4′-diglucosideB. orientale L.FrondsTLC[2,16]
11.Quercetin-3′,4′di methyl ether-3-glucosideB. orientale L.FrondsTLC[2,16]
12.Quercetin-3, glucuronideB. orientale L.FrondsTLC[2,16]
13.Quercetin 7′3′4′—TrimethoxyB. orientale L.Aerial partsGC-MS[23]
14.Quercetin 3-0-β-D-[6-0-caffeoylglucopyranoside]B. novae-zelandiae T.C.Chambers & P.A.FarrantFrondsHPLC, NMR[64]
15.Quercetin 3-0-β-D-[6-0-caffeoylgalactopyranoside]B. novae-zelandiae T.C.Chambers & P.A.FarrantFrondsHPLC, NMR[64]
16.Kaempferol-3,7-digalactosideB. orientale L.FrondsTLC[2,16]
17.Kaempferol-3,7-diglucosideB. orientale L.FrondsTLC[2,16]
18.Kaempferol-3,7-diglucuronideB. orientale L.FrondsTLC[2,16]
19.Kaempferol 3-0-β-D-glucuronopyranosideB. novae-zelandiae T.C.Chambers & P.A.FarrantFronds [64]
(d). Flavones
20.Luteolin-7-glucuronideB. orientale L.FrondsTLC[2,16]
21.Lucenin-2 (luteolin 6,8-di-C-glucoside)B. orientale L.Aerial parts [23]
22.Apigenin-7-glucuronideB. orientale L.FrondsTLC[2,16]
23.Isorhamnetin-3-glucosideB. orientale L.FrondsTLC[2,16]
24.Apigenin-7,4′-diglucosideB. orientale L.FrondsTLC[2,16]
25.Genkwanin-4′-glucuronideB. orientale L.FrondsTLC[2,16]
26.Acacetin-7-galactosideB. orientale L.FrondsTLC[2,16]
(e). Anthocyanidins
27.Apigeninidin-5-glucosideB. procerum (G.Forst.) SwFronds [17]
28.Apigeninidin-7-glucosideB. procerum (G.Forst.) SwFronds [17]
29.Apigeninidin-5-diglycosideB. procerum (G.Forst.) SwFronds [17]
30.Apigeninidin-7-diglycosideB. procerum (G.Forst.) SwFronds [17]
31.Apigeninidin-5-rhamnoside glucosideB. procerum (G.Forst.) SwFronds [17]
32.Apigeninidin-5-7-glycosideB. procerum (G.Forst.) SwFronds [17]
33.Luteolinidin-5-glucosideB. procerum (G.Forst.) SwFronds [17]
34.Luteolinidin-7-glucosideB. procerum (G.Forst.) SwFronds [17]
35.Luteolinidin-5-diglycosideB. procerum (G.Forst.) SwFronds [17]
36.Luteolinidin-7-diglycosideB. procerum (G.Forst.) SwFronds [17]
37.Luteolinidin -5-rhamnoside glucosideB. procerum (G.Forst.) SwFronds [17]
38.Luteolinidin-5-7-glycosideB. procerum (G.Forst.) SwFronds [17]
39.Luteolinidin 5-0-β-D-[3-0-
ß-D-glucopyranosyl-2-O-acetylglucopyranoside]
B. novae-zelandiae T.C.Chambers & P.A.FarrantFrondsHPLC, NMR[64]
Terpenoids
(a). Sesquiterpene
40.(E)-NerolidolB. spicant (L.) RothAerial partsGC-MS[11]
Diterpenes
41.NeophytadieneB. penna-marina (Maxon & C.V.Morton) Kuhn,
B. arcuatum Remy,
B. mochaenum G.Kunkel,
B. asperum (Klotzsch) J.W.Sturm,
B. blechnoides (Lag.) C.Chr.,
B. hastatum Kaulf,
B. microphyllum (Goldm.) C.V.Morton,
B. chilense (Kaulf.) Mett.,
B. magellanicum,
B. corralense Espinosa, and
B. occidentale L.
FrondsGC-MS[12,18]
42.Phytol ((3,7,11,15-tetramethyl-2-hexadecen-1-ol)B. penna-marina (Maxon & C.V.Morton) Kuhn,
B. arcuatum Remy,
B. mochaenum G.Kunkel,
B. asperum (Klotzsch) J.W.Sturm,
B. blechnoides (Lag.) C.Chr.,
B. hastatum Kaulf,
B. microphyllum (Goldm.) C.V.Morton,
B. chilense (Kaulf.) Mett.,
B. magellanicum (Desv.) Mett., and
B. corralense Espinosa.
FrondsGC-MS[18]
43.Isophytol ((3,7,11,15-tetramethyl-1-hexadecen-3-ol)B. penna-marina (Maxon & C.V.Morton) Kuhn,
B. arcuatum Remy,
B. mochaenum G.Kunkel,
B. asperum (Klotzsch) J.W.Sturm,
B. blechnoides (Lag.) C.Chr.,
B. hastatum Kaulf,
B. microphyllum (Goldm.) C.V.Morton,
B. chilense (Kaulf.) Mett.,
B. magellanicum (Desv.) Mett.,
B. corralense Espinosa, and
B. occidentale L.
FrondsGC-MS[12,18]
44.2-Hexadecene, 3,7,11,15-tetramethyl-, [R-[R*, R*-(E)]]-B. orientale L.Aerial partsGC-MS[23]
Sterols
45.EcdysoneB. penna-marina (Maxon & C.V.Morton) Kuhn,
B. arcuatum Remy,
B. mochaenum G.Kunkel,
B. asperum (Klotzsch) J.W.Sturm,
B. blechnoides (Lag.) C.Chr.,
B. hastatum Kaulf,
B. microphyllum (Goldm.) C.V.Morton,
B. chilense (Kaulf.) Mett.,
B. magellanicum (Desv.) Mett.,
B. corralense Espinosa,
B. vulcanicum (Blume) Kuhn, and
B. minus (R.Br.) Ettingsh
FrondsHPLC, GC-MS, NMR[14,18,26]
46.2-Deoxyecdysone (2-Deoxycrusteecdysone)B. vulcanicum (Blume) Kuhn,
B. minus (R.Br.) Ettingsh,
B. arcuatum Remy,
B. asperum (Klotzsch) J.W.Sturm,
B. blechnoides (Lag.) C.Chr.,
B. chilense (Kaulf.) Mett.,
B. corralense Espinosa,
B. hastatum Kaulf,
B. magellanicum (Desv.) Mett.,
B. microphyllum (Goldm.) C.V.Morton,
B. mochaenum G.Kunkel, and
B. penna-marina (Maxon & C.V.Morton) Kuhn
FrondsHPLC, GC-MS, NMR[14,18,26]
47.2-Deoxy-3-epiecdysoneB. vulcanicum (Blume) KuhnFrondsHPLC[14]
48.2-Deoxy-3-epi-20-hydroxyecdysoneB. vulcanicum (Blume) KuhnFrondsHPLC[14]
49.2-Deoxy-3-epiecdysone 3,22-diacetateB. vulcanicum (Blume) KuhnFrondsHPLC[14]
50.2-Deoxy-3-epiecdysone 3-acetateB. vulcanicum (Blume) KuhnFrondsHPLC[14]
51.2-Deoxy-3-epi-20-hydroxyecdysone 3-acetateB. vulcanicum (Blume) KuhnFrondsHPLC[14]
52.3α-Acetoxy ketodiolB. vulcanicum (Blume) KuhnFronds [14]
53.3β,14α-Dihydroxy-5α-cholest-7-en-6-oneB. vulcanicum (Blume) KuhnFrondsHPLC[14]
54.Deoxyviperidone 3-acetate.B. vulcanicum (Blume) KuhnFrondsHPLC[14]
55.3β,14α-Dihydroxy-5β-cholest-7-en-6-oneB. vulcanicum (Blume) KuhnFrondsHPLC[14]
56.PonasteroneB. penna-marina (Maxon & C.V.Morton) Kuhn,
B. arcuatum Remy,
B. mochaenum G.Kunkel, and
B. asperum (Klotzsch) J.W.Sturm.
B. blechnoides (Lag.) C.Chr.,
B. hastatum Kaulf,
B. microphyllum (Goldm.) C.V.Morton,
B. chilense (Kaulf.) Mett.,
B. magellanicum (Desv.) Mett., and
B. corralense Espinosa.
FrondsGC-MS, NMR[18,26]
57.ShidasteroneB. penna-marina (Maxon & C.V.Morton) Kuhn,
B. arcuatum Remy,
B. mochaenum G.Kunkel,
B. asperum (Klotzsch) J.W.Sturm,
B. blechnoides (Lag.) C.Chr.,
B. hastatum Kaulf,
B. microphyllum (Goldm.) C.V.Morton,
B. chilense (Kaulf.) Mett.,
B. magellanicum (Desv.) Mett., and
B. corralense Espinosa.
FrondsGC-MS, NMR[18,26]
58.Cholest-5-enolB. orientale L.Whole plantGC[13]
59.24-methycholesta-5,22-dienolB. orientale L.Whole plantGC[13]
60.24-methylcholest-5-enolB. orientale L.Whole plantGC[13]
61.24,-ethylcholesta-5,22-dienolB. orientale L.Whole plantGC[13]
62.24-ethylcholest-5-enolB. orientale L.Whole plantGC[13]
63.24-methylcholesterolB. orientale L.Whole plantGC[13]
64.24-α-ethyl-cholest-5-en-3β-olB. orientale L.Whole plantGC[13]
65.24-Alphaethyl-methyl-cholest-5- en-3-beta-olB. orientale L.Whole plantGC[13]
66.β-Sitosterol (Stigmast-5-en-3-ol)B. penna-marina (Maxon & C.V.Morton) Kuhn,
B. arcuatum Remy,
B. mochaenum G.Kunkel,
B. orientale L.,
B. asperum (Klotzsch) J.W.Sturm,
B. blechnoides (Lag.) C.Chr.,
B. hastatum Kaulf,
B. microphyllum (Goldm.) C.V.Morton,
B. chilense (Kaulf.) Mett.,
B. magellanicum (Desv.) Mett., and
B. corralense Espinosa.
Whole plantGC, GC-MS[13,18]
67.Stigmasterol (24- α-cholest-5-22-Dien-3-β-ol)B. orientale L.Whole plantGC[13]
68.Campesterol (ergost-5-en-3-ol)B. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
69.22-DehydrocampesterolB. orientale L.Whole plantGC[13]
Fatty acids
70.Palmitic acid (Hexadecanoic acid)B. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
71.Methyl palmitate (Hexadecanoic acid, methyl ester)B. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
72.Linolenic acid (9,12,15-octadecatrienoic acid)B. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
73.Linoleic acid (9,12-octadecadienoic acidB. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
74.Oleic acid (9-octadecenoic acid).B. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
75.Methyl linoleate (9,12-octadecadienoic acid, methyl ester)B. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
76.Methyl linolenate (9,12,15-octadecatrienoic acid, methyl ester)B. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
77.Hexanedioic acid, bis (2-ethylhexyl) esterB. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
78.Tetradecanoic acid 2,3-diacetoxy-propyl esterB. occidentale L.,
B. binervatum (Poir.) C.V.Morton & Lellinger, and
B. brasiliense Desv.
FrondsGC-MS[12]
79.1,2,3-Propanetricarboxylic acid 2-hydroxy-, triethyl esterB. orientale L.Whole plantGC-MS[23]
80.Hexanedioic acid, mono (2-ethylhexyl) esterB. orientale L.Whole plantGC-MS[23]
81.Nonanoic acidB. spicant (L.) RothAerial partsGC-MS[11]
Alcohols
82.1-Octen-3-olB. spicant (L.) RothAerial partsGC-MS[11]
83.3-OctanolB. spicant (L.) RothAerial partsGC-MS[11]
84.(E)-2-OctenolB. spicant (L.) RothAerial partsGC-MS[11]
85.3,7-Dimethyloctan-3-olB. spicant (L.) RothAerial partsGC-MS[11]
Aldehydes
86.(E)-2-HeptenalB. spicant (L.) RothAerial partsGC-MS[11]
87.2-PhenylethanalB. spicant (L.) RothAerial partsGC-MS[11]
88.BenzaldehydeB. spicant (L.) RothAerial partsGC-MS[11]
Carotenoids
89.Epoxy-α-iononeB. spicant (L.) RothAerial partsGC-MS[11]
90.4-Hydroxyepoxy-β-ionolB. spicant (L.) RothAerial partsGC-MS[11]
Heterocyclic
91.3-benzoyl-4-methyl-6-ethyl-2(1H)-PyridoneB. orientale L.Whole plantGC-MS[23]

3.5. Other Compounds

Blechnum species are significant sources of other phytochemicals including alcohols (8285), aldehydes (8688), carotenoids (8990), and heterocyclic (91) compounds. The chemical structures of some of the isolated compounds are illustrated in Figure 10 below. The phytochemical investigation of several fern species by Fons et al. [11], using the diethyl ether extracts, resulted in detection of compounds (8690) from the aerial parts of B. spicant (Table 2). In addition, a heterocyclic compound (91) was isolated from the whole plant of B. orientale [23].

4. Pharmacological Activity

Beneficial medicinal plants, as demonstrated by the presence of specialized metabolites, are ideal resources for revealing novel discoveries for therapeutic advances and breakthroughs. Medicinal plants serve as alternatives to modern medicines in most of the world’s populations [20]. Some Blechnum plants are significant sources of traditional remedies for different illnesses (Table 1), which have recently motivated the exponential increase in pharmacological research. Crude extracts and several specialized products isolated from this genus exhibit a wide range of biological activities, including the antioxidant, antimicrobial, anti-inflammatory, anticancer, wound healing, insecticidal, and antitrematocidal activities described in this section.

4.1. Antioxidant Activity

Antioxidants are chemical compounds that play critical roles in preventing or delaying lipid peroxidation and scavenging free radicals, which are major causes of diseases in humans and other animals [65]. The ability of medicinal plants to scavenge 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radicals has been reported in the Blechnaceae family [66,67,68]. Several studies evaluated the antioxidant properties of various extracts obtained from the Blechnum plants. The fractions at 2–1000 µg/mL prepared from the leaves of B. orientale showed significant scavenging effects, comparable to the positive controls. The ethyl acetate fraction (EAf) displayed the strongest activity, equivalent to Trolox-C (IC50 8.6 µg/mL) and greater than butylated hydroxytoluene (BHT) (IC50 17.2 µg/mL) and tocopherol (IC50 12.0 µg/mL) controls [2].
Similarly, the biological properties of hexane (HX) and dichloromethane (DCM) fractions obtained from the fronds of B. binervatum, B. brasiliense, and B. occidentale was tested at the concentrations of 1-500 µg/mL. Both extracts showed potent activities (<180 µg/mL), with DCM (IC50 15.85 ± 1.79 µg/mL) and HX (IC50 22.02 ± 1.09 µg/mL) fractions prepared from B. brasiliense exhibiting the highest scavenging capacity, uncomparable with the chlorogenic (IC50 45.6 ± 1.52 µM) and caffeic (IC50 63.3 ± 1.43) µM acid controls. Furthermore, the extracts displayed a remarkable inhibitory effect against lipoperoxidation in the homogenates prepared from rat brain (IC50 56–95 µg/mL), with HX (IC50 56.19 ± 1.08 µg/mL) and DCM (IC50 68.48 ± 1.24 µg/mL) fractions from B. brasiliense exhibiting strongest activities with no harmful effects. Correspondingly, the DCM extracts showed strong inhibitory activity (IC50 31.83 µg/mL) against monoamine oxidase [12].
Andrade et al. [44] investigated the in vitro antioxidant of various extracts (1–500 μg/mL) obtained from B. binervatum, B. brasiliense, and B. occidentale on neurodegenerative-related multi-targets. The extracts showed high scavenging abilities (IC50 112.3 ± 2.61–311.1 ± 1.66 μg/mL) with B. brasiliense (IC50 112.3 ± 2.61 μg/mL) exhibiting the strongest activity, while low activities (IC50 < 500 μg/mL) were revealed in nitric oxide (NO) and cholinesterase inhibitions assays. Additionally, the screened metabolites; chlorogenic (IC50 37.5 ± 1.25 μM) and caffeic (55.9 ± 1.22 μM) acids demonstrated significant antioxidant activities. The cytotoxic effects were absent in both polymorphonuclear cells (PMN) and human stem cells as indicated by MTT assay. In another study, the extracts obtained from the leaves of B. chilense showed notable DPPH scavenging activity compared to the α-tocopherol control [39]. Tyrosinase activities of B. orientale extracts was moderately correlated with the antioxidant properties, supported weakly by dopachrome test [69].
Finally, the variously eluted fractions prepared from the concentrated extracts (5 g) of the whole plant of B. orientale using 820, 550, and 665 milligrams (mg) of HX, carbon tetrachloride, and chloroform, respectively. The elutes indicated significant antioxidant activities, with fraction VI displaying the strongest activities (64.4%) when compared to BHT (98.3%) standard. The phenolic compounds quercetin-7′,3′,4′-trimethoxy (12), and diterpene phytol (42), were associated with the exhibited antioxidant activity of B. orientale [23].

4.2. Antimicrobial Activity

A rigorous search for new antibiotics has been necessitated by the prompt development of drug-resistant strains of pathogens. Medicinal plants resources are potential candidates as antimicrobial agents, prompting extensive screenings to test their antimicrobial efficacy. In the present review, B. orientale was found to be an outstanding source of natural antimicrobial agents, and various investigations are discussed below.

4.2.1. Antibacterial Activity

The antibacterial activities of B. orientale validates the traditional medicinal assertion as remedies to various infectious bacterial ailments such as ulcers, skin diseases, boils, stomach discomfort, wounds, blisters, sores, and urinary bladder complaints (Table 1). Lai et al. [2] assessed the antibacterial potential of several extracts, including crude, butanol, water, and ethyl acetate extracted from the leaves of B. orientale, using the broth microdilution and disc diffusion assays against 10 (Gram-positive and Gram-negative) bacterias. The tested fractions exhibited significant activities (MIC 62.5–125 µg/mL; MBC 62.5–125 µg/mL) towards Micrococcus luteus, Bacillus cereus, methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), and S. epidermidis. The activities of water and butanol fractions towards B. cereus and S. aureus were comparable to other related investigations [70] and stronger (MIC 62.5 µg/mL) than the values reported by Grierson & Afolayan, [71] (MIC 500–5000 µg/mL) and Kaur & Arora, [72] (MIC 20–80 mg/mL). However, no activity was exhibited towards the Gram-negative bacterias.
Additionally, the acetone extract obtained from the leaves of B. orientale was tested against S. aureus, Bacillus subtilis, Klebsiella pneumonia, Salmonella typhi, Streptococcus pyogenes, Proteus vulgaris, Pseudomonas sp., and Serratia sp. at a dosage of 1 mg/disc [28]. Remarkable antibacterial activity was revealed by the maximum inhibition of P. vulgaris (MIC 0.025 mg/mL), while minimum zones were exhibited against B. subtilis and S. aureus. In another investigation, the leaves extract of B. orientale was tested against eight strains of bacterias encompassing M. luteus, B. cereus, S. aureus (Gram-positive), Escherichia coli, Pseudomonas aeruginosa, Salmonella choleraesuis, Enterobacter aerogenes, and Klebsiella pneumonia (Gram-negative), with methanol and streptomycin (10 mg) used as positive and negative controls, respectively. The three bacteria; M. luteus (48% inhibition, MID 500 mg/disc), B. cereus (57% inhibition, MID 500 mg/disc), and S. aureus (63% inhibition, MID 250 mg/disc), exhibited significant activities, which were comparable to streptomycin, while no inhibitions were reported for Gram-negative bacteria [72]. Insensitivity of the Blechnum extracts against the latter indicate the higher resistance of Gram-negative bacteria towards plant extracts compared to Gram-positive strains, consistent with other studies [73,74].
Finally, bacterial pathogens including S. aureus, B. subtilis, S. typhi, M. luteus, P. aeruginosa and E. coli were clinically isolated in an in-vitro antimicrobial efficacy trial using B. orientale extracts (pet-ether, chloroform, methanol, and aqueous) at 500 and 1000 µg/mL concentration. The extracts displayed remarkable inhibitions against E. coli at both 500 µg/mL (16.13 ± 0.09–20.2 ± 0.17 mm) and 1000 µg/mL (21.7 ± 0.16–24.0 ± 0.18 mm) concentrations, while P. aeruginosa showed significant inhibitions (11.0 ± 0.06–14.13 ± 0.09 mm) at 500 µg/mL. However, no inhibitions were exhibited by S. typhi and the rest of the Gram-positive bacterias. Both extracts were sensitive against Gram-negative bacteria, with strong sensitivity at 250 µg/mL observed in chloroform and aqueous extracts against E. coli. In addition, the maximum inhibitory concentration of both extracts against P. aeruginosa was exhibited at 250 µg/mL [19]. Thus, Blechnum plants are potential antibacterial agent in development of alternative phytomedicines, and this justifies the popular traditional medicinal uses in the treatment of bacterial-related infections.

4.2.2. Antifungal Activity

In Blechnum genus, the extracts obtained from B. orientale were studied for antifungal activity. Deepa et al. [19] obtained various extracts prepared from the fronds at the concentration of 500 and 1000 µg/mL against Candida albicans and Aspergillus flavus. The results showed high antifungal activity against C. albicans at the concentration of 1000 µg/mL with 11.0 ± 0.09–12.13 ± 0.09 mm zones of inhibition compared to the standard fluconazole- 25.12 mm, while no inhibition activity was indicated towards A. flavus.

4.3. Anti-Inflammatory Activity

Inflammation might occur in the absence of illness (sterile inflammation) or as a self-defence mechanism against pathogens when the body responds to tissue injury [75,76,77]. The inflammation-related illnesses are commonly treated with steroidal or non-steroidal chemical medicines in pharmaceuticals [78]. However, these drugs have been shown to potentially induce toxicity and diverse side effects [79,80,81]. Thus, exploring new analgesic and anti-inflammatory agents with fewer negative effects is of great concern.
The various tests such as writhing, formalin, tail flick, paw oedema, and leukocyte migration were conducted to evaluate the anti-inflammatory and antinociceptive activities of the extracts derived from B. occidentale [3]. The mice were intraperitoneally (IP) and orally administered with the prepared extracts at the concentration ranges of 0.01–100 mg/kg and 100–400 mg/kg, respectively. The orally administered extracts dose-dependently induced writhing and showed significant antinociceptive effects. Additionally, the paw oedema induced by carrageenan and neutrophil migration was potentially reduced on intraperitoneal treatment with no cytotoxicity (p < 0.01).
In another study, Fasolo et al. [82] used the adult zebrafish to investigate the anti-inflammatory properties of rosmarinic acid, a bioactive molecule derived from the fronds of B. brasiliense by lipopolysaccharide induction model. In this trial, the intraperitoneal (i.p.) injection of lipopolysaccharides (LPS) was administered to induce a neuroinflammation cascade. The results indicated the promotion of TNF-α and IL-1β in zebrafish brain content within 24 h. Co-treatment with rosmarinic acid at the concentration of 2.5–7.5 mg/kg, and further LPS administration, showed the capability of the latter compound to reduce TNF-α and IL-1β levels. The compound exhibited a dose-dependent anti-inflammatory effects, with the highest concentration (7.5 mg/kg), greatly decreasing the TNF-α levels (p = 0.0026) and IL-1β levels (p = 0.0053) 6 h after the induction of LPS, while they were reduced in lower doses and somewhat prevented their augmentation. The investigated properties validate the traditional use of Blechnum species in treating various ailments, including inflammations, liver, urinary, and pulmonary infections.

4.4. Anticancer Activity

Cancer is among the leading cause of mortality today, and is characterized by uncontrolled growing and spreading of abnormal cells [83]. The burden of cancer incidence and deaths are globally accelerating with about 2.3 million new cases of female breast cancer reported recently to be among the most commonly diagnosed type of cancer infection [84], which results in nearly 40,000 deaths annually. Thus, various medicinal plants in the Blechnaceae family, such as the Blechnum plants, were tested for cancer treatment to replace modern medicines. The in vitro cytotoxic potential of different extracts ranging from 0.1 to 100 μg/mL concentration were prepared from the leaves, stems, and roots of B. orientale and investigated against the human breast cancer cell line (MCF-7wt.). Cells with oestrogen receptors (ER+) were models for assessing the events linked to chemotherapic responses of MCF-7wt. The cell viability of the roots, leaves, and stems extracts were 31.47%, 81.44%, 89.05% respectively. The extracts obtained from roots displayed cytotoxicity values of IC50 value of 32.07 ± 7.85 μg mL−1, with 19.1% cell mortality, and thus can be a vital source of cancer treatment [20].
Furthermore, Lai et al. [2] tested the various extracts obtained from B. orientale against four cancer cell lines. The butanol (Butf) (IC50 27.5 µg/mL), water (Watf) (IC50 33.4 µg/mL), and ethyl acetate (EAf) (IC50 42.8 µg/mL) fractions revealed remarkable cytotoxic activities against the colonic adenocarcinoma cell (HT-29). However, the obtained values were weaker than curcumin (IC50 5.4 µg/mL). In addition, notable activities were displayed by Butf fractions (IC50 72.7 µg/mL) towards the human colonic carcinoma cell (HCT-116), unlike the human breast adenocarcinoma (MCF-7), human leukemia (K562), as well as liver Chang cells which demonstrated negligible cytotoxic potential (IC50 > 100 µg/mL).

4.5. Wound Healing Activity

Wounds are caused by physical, thermal, chemical, or microbial damage to living tissues, disrupting their normal functioning [85]. The wound-healing process is currently facing clinical challenges due to the observed inconsistencies at various stages [86]. The absence of effective modern medicines has instigated intense searches for alternative novel natural medicines. Many medicinal plants were scientifically proven as sources of therapeutics for wounds [87], consistent with the holistic approach by traditional systems toward curing various wound-related illnesses. However, only a single species in the Blechnum genus has been assessed for its wound-healing properties. Since antiquity, B. orientale has long been reported as a vital source of traditional remedies against wound-related complaints [31,32]. Pharmacogical studies support the traditional therapeutic assertion against skin-related ailments.
Lai et al. [22] used an in vivo assay technique to investigate the effects of water extracts obtained from the leaves of B. orientale on Sprague-Dawley rats wound healing. In this study, the animals were segregated into four groups, each consisting of six specimens, and were intraperitoneally administered with either 100 mg/kg of ketamine or 10 mg/kg xylazine in order to anesthetize them, followed by the subcutaneous injection of 5 mg/kg carprofen as an analgesia. The treatment groups were segregated into 1% and 2% water extracts and monitored daily. Controls were applied with the dosage of 0.20 g/wound once a day until healing/14 days. The size of wounds and the mean duration of epithelisation were significantly reduced in both cases. The 2% extract exhibited outstanding activities with wound contraction of 128.7 ± 13.4–0.8 ± 0.9 mm2 within 14 days, compared to 1% extract (139.7 ± 15.4–8.8 ± 0.9 mm2), which indicated interesting dose-dependent wound healing properties (p < 0.001) compared to both negative (163.7 ± 10.4–25.5 ± 6.4 mm2) and positive (133.7 ± 12.0–5.0 ± 0.9 mm2) controls dressed in the base cream and 10% povidone-iodine, respectively. Additionally, the collagen synthesis was higher in the group treated with 2% water extract compared to the vehicle group and 1% extract. More investigations are warranted to strongly authenticate the medicinal uses of Blechnum species.

4.6. Insecticidal Activity

Novel environmentally safe natural products from plants have been extensively exploited in search of alternative agents for synthetic pesticides aimed to effectively control insects [88,89]. Numerous medicinal plants were revealed to have significant insecticidal properties in the Blechnaceae family [18,90]. Monsalve et al. [26] used the ethyl acetate (EtOAc) and n-hexane (HX) fractions obtained from B. chilense to investigate it’s insecticidal potential. Drosophila melanogaster was treated with the prepared extracts at 200 to 800 ppm concentration ranges, while distilled water was used as a control. The extracts concentration-dependently affected development of the studied insects and induced larval mortality by 66.7% (EtOAc) and 63.3% (HX). At lower concentrations, the fractions showed either less mortality or less harmful effects. The isolated compound (ponasterone) was linked to the insecticidal activity of B. chilense. This metabolite showed a high affinity for ecdysone receptors found in Kc cells of D. melanogaster [60]. In addition, the prepared EtOAc extract concentration at 500 µg/mL obtained from the leaves of B. chilense showed toxicity (insecticidal efficacy) against Galleria mellonella larvae and induced premature pupal stage, exhibiting regulatory properties towards the development of larvae. The phytoecdysteroides compounds were potential constituents associated with the insecticidal property of Blechnum species [21]. Ecdysteroids hormones found in insects play a novel role in their metamorphosis. Since phytoecdysteroids metabolites have structural similarities with insect ecdysteroids hormones, plants containing this compounds act as remarkable anti-feedant agents with deterrent activities, and may instigate pathophysiological effects and organism death [91,92,93].

4.7. Antitrematocidal Activity

Anthelmintic resistance has become a global challenge, especially among farmers due to the parasitism which develops when synthetic anthelmintic drugs are frequently used. Alternatively, natural antiparasitic plant-derived products have been reported to effectively overcome resistance [5,94,95]. Pteridophytes have been demonstrated to be potential sources of trematodicidal drugs. Selected medicinal ferns, including B. orientale, were investigated for their in vitro antitrematodal activities [5]. The prepared eluates at 1 to 5 mg/mL concentration were examined against Gastrothylax crumenifer by incubating the test group with test extracts for one hour while recurrently observing their mobility, paralysis, and death. In addition, oxyclozanide (0.25 g/25 mL) was used as a standard control while a Hedon-Fleig (HF) salt solution was used as a negative control. The extracts showed the evidence of concentration-dependent increase in trematodicidal activities, and all amphistomes were killed at 5 mg/mL, similar to oxyclozanide, at the first ten minutes of incubation. The absence of mortality was reported for the entire incubation period at 1 mg/mL, while the concentration between 2–4 mg/mL caused partial mortality.
Devi et al. [23] performed an in vitro bioassay to assess the trematocidal potency of the extracts prepared from the whole plant of B. orientale against G. crumenifer. The test groups (25 amphistomes) were incubated with 25 mL of the extract fractions ranging from 1 to 5 mg concentration. In contrast, 0.25 g/25 mL of oxyclozanide was used as a control and visually observed at regular intervals for their mobility. Qualitative analysis indicated that the ethanol extracts concentration-dependently exhibited remarkable trematocidal activities against G. crumenifer. The most potent effects observed by duration taken to kill the trematodes were displayed at 5 mg concentration and were not comparable to oxyclozanide control. The screened phytochemical compounds, including quercetin-7′,3′,4′-trimethoxy (compound 12), and phytol isomer (42), were associated with the antitrematocidal efficacy of B. orientale. These specialized metabolites targeted the tegumental regions, which caused varied changes in enzymes at predilection sites. The shifts in tegumental enzymes restricted the metabolic action of trematodes resulting in the death of worms. However, more in vitro and in vivo investigations are essential to authenticate Blechnum species as vital sources of novel anthelmintic plant-derived drugs.

4.8. Other Activities

In addition to the above-mentioned biological activities, B. orientale has been shown to have significant inhibitory activity (EC50 = 65.78 µg/mL) against α-glucosidase when compared to the myricetin control. As a result, this plant could be an interesting source of natural antidiabetic agents [96].
In the Blechnum genus, several species including B. orientale, B. binervatum, B. brasiliense, and B. chilense were reported to have pharmacological relevance (Figure 11). Blechnum orientale was widely studied, followed by B. occidentale and B. brasiliense, respectively, while B. chilense and B. binervatum were least studied. The reported biological properties including antioxidant, antimicrobial, anti-inflammatory and antinociceptive, wound healing, anticancer, and antitrematocidal activities concern different ailments and support the traditional assertion as treatments for influenza, typhoid, pulmonary infections, cancer, skin illnesses, inflammation, and intestinal wounds.

5. Conclusions

In the present review, we compiled information on the chemical constituents and biological activities of the Blechnum species. This genus encompasses several medicinally significant plants with numerous specialized metabolites such as alcohols, aldehydes, carotenoids, phenolic compounds, fatty acids, sterols, and terpenoids. A wide range of pharmacological effects such as antioxidant, antimicrobial, anti-inflammatory, anticancer, wound healing, insecticidal, and antitrematocidal properties were exhibited by the plant extracts and isolated metabolites. Several terpenoids and flavonoids metabolites were associated with antioxidant, antitrematocidal, and insecticidal activities. However, the pharmacological activities of most specialized metabolites listed in this review have yet to be investigated.
Although the genus has reported interesting medicinal uses, there are still several gaps that limit understanding of the scientific implications of several medicinally used Blechnum species. Foremost, only 20 of the 236 recognized species in the genus Blechnum have been evaluated for phytochemistry and bioactivities, while numerous other species are still unexplored. Secondly, most pharmacological analyses centered on crude extracts, with no emphasis on the specific metabolites associated with biological activities. Thirdly, in vitro models were mainly explored in assessing the pharmacological properties, with only a few studies employing the in vivo systems. In addition, the observed bioactivities were mainly random screenings with no link between traditional uses and pharmacological activities. Lastly, only a single report described the underlying modes of action of bioactive metabolites with pharmacological effects. These afore-mentioned aspects associated with the medicinal uses of the Blechnum species necessitate further investigations to warrant their pharmaceutical applications.
Importantly, the present review demonstrates the scientific basis for some of the medicinal uses of a variety of Blechnum species and supports their traditional therapeutic uses as remedies for various illnesses, validated by the majority of the pharmacological properties. Further investigations are required to extensively screen the specialized metabolites and investigate their biological activities to bring new fascinating findings and expound on the scientific basis of Blechnum for safe clinical application.

Author Contributions

Conceptualization, G.-W.H. and E.N.W.; writing—original draft preparation, F.W.M.; writing—review and editing, E.N.W.; drawing the phytochemical compounds, E.S.M., C.N. and E.M.M.; revising phytochemical compounds, F.W.M. and W.O.O.; revising Traditional uses and pharmacological properties, J.L. and S.-X.D.; supervision, S.G.A.; grammar, G.-W.H.; funding acquisition, G.-W.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (31961143026, 31970211), the National Science & Technology Fundamental Resources Investigation Program of China (2019FY101800), the International Partnership Program of the Chinese Academy of Sciences (151853KYSB20190027) and Sino-Africa Joint Research Center, CAS (SAJC202101).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare that they have no conflict of interest.

References

  1. Baskaran, X.; Vigila, A.G.E.O.; Zhang, S. A review of the use of pteridophytes for treating human ailments. J. Zhejiang Univ. Sci. B 2018, 19, 85–119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Lai, H.Y.; Lim, Y.Y.; Kim, K.H. Blechnum Orientale Linn—A fern with potential as antioxidant, anticancer and antibacterial agent. BMC Complement. Altern. Med. 2010, 10, 15. [Google Scholar] [CrossRef] [Green Version]
  3. Regina, N.F.; Barros, T.A.A.; Lucchese, A.M.; Oliveira, C.E.C.; Santos, R.R.; Soares, M.B.P.; Villarreal, C.F. Antiinflammatory and antinociceptive activities of Blechnum occidentale L. extract. J. Ethnopharmacol. 2009, 125, 102–107. [Google Scholar] [CrossRef]
  4. Bresciani, L.F.V.; Priebe, J.P.; Yunes, R.A.; Magro, J.D.; Monache, F.D.; de Campos, F.; Cechinel-Filho, V. Pharmacological and phytochemical evaluation of Adiantum cuneatum growing in Brazil. Zeitschrift Naturforsch. 2003, 58, 191–194. [Google Scholar] [CrossRef]
  5. Rajesh, N.V.; Vasantha, S.; Jeyathilakan, N. Screening of in vitro antitrematodal activities of compounds and secondary metabolites isolated from selected Pteridophytes. Vet. Ital. 2020, 56, 271–287. [Google Scholar]
  6. Brownsey, P.J.; Perrie, L.R. Ophioglossaceae. In Flora of New Zealand—Ferns and Lycophytes. Fascicle 14; Breitwieser, I., Heenan, P.B., Wilton, A.D., Eds.; Manaaki Whenua Press: Lincoln, New Zealand, 2015. [Google Scholar]
  7. Mendoza-Ruiz, A. Morphogenesis of the gametophytes of eight Mexican species of Blechnum (Blechnaceae). Acta Bot. Mex. 2009, 88, 59–72. [Google Scholar] [CrossRef] [Green Version]
  8. Benjamin, A.; Manickam, V.S. Medicinal pteridophytes from the Western Ghats. Indian J. Tradit. Knowl. 2007, 6, 611–618. [Google Scholar]
  9. Upreti, K.; Jalal, J.S.; Tewari, L.M.; Joshi, G.C.; Pangtey, Y.P.S.; Tewari, G. Ethnomedicinal uses of Pteridophytes of Kumaun Himalaya, Uttarakhand, India. J. Am. Sci. 2009, 5, 167–170. [Google Scholar]
  10. Salehi, B.; Quispe, C.; Sharifi-Rad, J.; Cruz-Martins, N.; Nigam, M.; Mishra, A.P.; Konovalov, D.A.; Orobinskaya, V.; Abu-Reidah, I.M.; Zam, W. Phytosterols: From preclinical evidence to potential clinical applications. Front. Pharmacol. 2021, 11, 1819. [Google Scholar] [CrossRef]
  11. Fons, F.; Froissard, D.; Bessière, J.; Buatois, B.; Fons, F.; Froissard, D.; Bessière, J.; Buatois, B.; Rapior, S. Biodiversity of volatile organic compounds from five French ferns. Nat. Prod. Commun. 2010, 5, 1655–1658. [Google Scholar] [CrossRef] [Green Version]
  12. Maria, J.; Andrade, D.M.; Maurmann, N.; Pranke, P.; Casanova, I.C. Identification of compounds from non-polar fractions of Blechnum spp and a multitarget approach involving enzymatic modulation and oxidative stress. J. Pharm. Pharmacol. 2017, 69, 89–98. [Google Scholar] [CrossRef]
  13. Chiu, P.; Patterson, W.; Salt, T.A. Sterol composition of pteridophytes. Phytochemistry 1988, 27, 819–822. [Google Scholar] [CrossRef]
  14. Russell, G.B.; Greenwood, D.R.; Lane, G.A.; Blunt, J.W.; Munro, M.H.G. 2-Deoxy-3-epiecdysone from the fern Blechnum vulcanicum. Phytochemistry 1981, 20, 2407–2410. [Google Scholar] [CrossRef]
  15. Wada, H.; Kido, T.; Tanaka, N.; Murakami, T.; Saiki, Y.; Chen, C.-M. Chemical and chemotaxonomical studies of ferns. LXXXI. Characteristic lignans of Blechnaceous ferns. Chem. Pharm. Bull. 1992, 40, 2099–2101. [Google Scholar] [CrossRef]
  16. Yusuf, U.K. Flavonoid glycosides in the fern Blechnum orientale Linn. Am. Fern J. 1994, 84, 69–70. [Google Scholar] [CrossRef]
  17. Crowden, R.K.; Jarman, S.J. 3-deoxyanthocyanins from the fern Blechnum procerum. Phytochemistry 1974, 13, 1947–1948. [Google Scholar] [CrossRef]
  18. Flores-González, M.; Torres-Benítez, A.; Simirgiotis, M. Terpenic Compounds in Chilean Species of the Genus Blechnum (Pteridophyta: Blechnaceae) with Neuroprotective. Multidiscip. Digit. Publ. Inst. Proc. 2021, 71, 8535. [Google Scholar] [CrossRef]
  19. Deepa, J.; Parashurama, T.R.; Krishnappa, M.; Nataraja, S. Antimicrobial efficacy of Blechnum orientale L. Int. J. Pharma Bio Sci. 2013, 4, P475–P479. [Google Scholar]
  20. Aini, N.; Shukor, A.; Stanslas, J. Cytotoxic Potential on Breast Cancer Cells Using Selected Forest Species Found in Malaysia. Int. J. Cancer Res. 2008, 4, 103–109. [Google Scholar] [CrossRef] [Green Version]
  21. Zapata, N.; Ceballos, R.; Cespedes, C.; Alarcon, J.; Leyton, A. Insecticidal activity and growth regulatory of Blechnum chilense (Blechnaceae) and Condalia microphylla Cav. (Rhamnaceae) extracts, on larvae of Galleria mellonella (Linnaeus) (Lepidoptera: Pyralidae). Boletín Latinoam. Caribe Plantas Med. Aromáticas 2016, 15, 77–87. [Google Scholar]
  22. Lai, H.Y.; Lim, Y.Y.; Kim, K.H. Potential dermal wound healing agent in Blechnum orientale Linn. Complement. Altern. Med. 2011, 11, 1–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Devi, R.K.; Vasantha, S.; Panneerselvam, A.; Rajesh, N.V.; Jeyathilakan, N. Phytochemical constituents and in vitro trematocidal activity of Blechnum orientale Linn. against Gastrothylax crumenifer. Ann. Phytomed. 2016, 5, 127–134. [Google Scholar]
  24. Fraser-Jenkins, C.R. Rare and Threatened Pteridophytes of Asia 2. Endangered Species of India—The Higher IUCN Categories. Bull. Natl. Mus. Nat. Sci. Ser. B 2012, 38, 153–181. [Google Scholar]
  25. Galán, J.M.G.Y.; Prada, C.; Rolleri, C.; Ainouche, A.; Vicent, M. cpDNA supports the identification of the major lineages of American Blechnum (Blechnaceae, Polypodiopsida) established by morphology. Turk. J. Bot. 2013, 37, 769–777. [Google Scholar] [CrossRef] [Green Version]
  26. Monsalve, Z.I.; Parada, K.; Lamilla, C. Insect Growth Regulatory Activity of Blechnum chilense. NPC Nat. Prod. Commun. 2011, 8, 1085–1088. [Google Scholar] [CrossRef] [Green Version]
  27. Ho, R.; Teai, T.; Bianchini, J.-P.; Lafont, R.; Raharivelomanana, P. Ferns: From traditional uses to pharmaceutical development, chemical identification of active principles. In Working with Ferns; Springer: Berlin/Heidelberg, Germany, 2011; pp. 321–346. [Google Scholar]
  28. Maridass, M.; Ghantikumar, S. Antibacterial activity of leaves of Blechnum orientale L. Pharmacol. Newslett. 2008, 3, 58–60. [Google Scholar]
  29. Gupta, A. Applications and uses of active ingredients from medicinal plants. Indian J. Nov. Drug Deliv. 2016, 6, 106–111. [Google Scholar]
  30. May, L.W. The economic uses and associated folklore of ferns and fern allies. Bot. Rev. 1978, 44, 491–528. [Google Scholar] [CrossRef]
  31. Ahmad, F.B.; Holdsworth, D.K.; Ahmad, F.B.; Holdsworth, D.K. Medicinal Plants of Sabah, East Malaysia–Part. Pharm. Biol. 2003, 41, 340–346. [Google Scholar] [CrossRef]
  32. Kumar, D.G.; Syafiq, A.M.; Ruhaiyem, Y.; Shahnaz, M. Blechnum orientale Linn. An Important Edible Medicinal Fern. Int. J. Pharm. Phytochem. Res. 2015, 7, 723–726. [Google Scholar]
  33. Ong, H.C.; Lina, E.; Milow, P. Traditional knowledge and usage of medicinal plants among the Semai Orang Asli at Kampung Batu 16, Tapah, Perak, Malaysia. Stud. Ethno-Med. 2012, 6, 207–211. [Google Scholar] [CrossRef]
  34. Dixit, R.D.; Vohra, J.N. A Dictionary of the Pteridophytes of India; Botanical Survey of India, Department of Environment: Kolkata, India, 1984.
  35. Shil, S.; Choudhury, M.D. Ethnomedicinal Importance of Pteridophytes Used by Reang tribe of Tripura, North East India. Ethnobot. Leafl. 2009, 2009, 10. [Google Scholar]
  36. Karthik, V.; Raju, K.; Ayyanar, M.; Gowrishankar, K.; Sekar, T. Ethnomedicinal uses of pteridophytes in kolli hills, Eastern Ghats of Tamil Nadu, India. J. Nat. Prod. Plant Resour 2011, 1, 50–55. [Google Scholar]
  37. Tsai, H.-H.; Hwang, S.-M. Compositions of Matter Useful in the Treatment of Viral Infections Derived from Plant. U.S. Patent 5989556, 23 November 1999. [Google Scholar]
  38. Barros, I.C.L.; Andrade, L.H.C. Pteridófitas Medicinais (Samambaias, Avencas e Plantas Afins). Federal University of Pernambuco: Recife, Brazil, 1997. [Google Scholar]
  39. Carlos, A.; David, S. Antioxidant activity of Blechnum chilense (Kaulf.) Mett. Curcuma domestica Valeton and Tagetes verticillata Lag. & Rodriguez. Boletín Latinoam. Caribe Plantas Med. Aromáticas 2011, 10, 315–324. [Google Scholar]
  40. Goswami, H.K.; Sen, K.; Mukhopadhyay, R. Pteridophytes: Evolutionary boon as medicinal plants. Plant Genet. Resour. 2016, 14, 328–355. [Google Scholar] [CrossRef]
  41. DeFilipps, R.A.; Maina, S.L.; Crepin, J. Medicinal Plants of the Guianas (Guyana, Surinam, French Guiana); Smithsonian Institution: Washington, DC, USA, 2004. [Google Scholar]
  42. Bohm, B.A. Phenolic compounds in ferns—III: An examination of some ferns for caffeic acid derivatives. Phytochemistry 1968, 7, 1825–1830. [Google Scholar] [CrossRef]
  43. Minatel, I.O.; Borges, C.V.; Ferreira, M.I.; Gomez, H.A.G.; Chen, C.-Y.O.; Lima, G.P.P. Phenolic compounds: Functional properties, impact of processing and bioavailability. Phenolic Compd. Biol. Act 2017, 8, 1–24. [Google Scholar]
  44. Andrade, J.M.M.; Biegelmeyer, R.; Dresch, R.R.; Maurmann, N.; Pranke, P.; Henriques, A.T. In vitro Antioxidant and Enzymatic Approaches to Evaluate Neuroprotector Potential of Blechnum Extracts Without Cytotoxicity to Human Stem Cells. Pharmacogn. Mag. 2016, 12, 171. [Google Scholar] [CrossRef] [Green Version]
  45. Andrade, J.M.M.; Passos, S.C.; Rubio, M.A.K.; Mendonça, J.N.; Lopes, N.P.; Henriques, A.T. Combining in vitro and in silico approaches to evaluate the multifunctional profile of rosmarinic acid from Blechnum brasiliense on targets related to neurodegeneration. Chem.-Biol. Interact. 2016, 254, 135–145. [Google Scholar] [CrossRef]
  46. Petersen, M.; Simmonds, M.S.J. Rosmarinic acid. Phytochemistry 2003, 62, 121–125. [Google Scholar] [CrossRef]
  47. Caro-León, J.; Espinosa-Cano, E.; Rosa, M.; Huerta-Madroñal, M.; Blanca, V. Chitosan—Rosmarinic acid conjugates with antioxidant, anti-inflammatory and photoprotective properties. Carbohydr. Polym. 2021, 273, 118619. [Google Scholar] [CrossRef]
  48. Augusto, A.; Lataliza, B.; De Assis, P.M.; Laurindo, R.; Cristina, E.; Gonçalves, D.; Dutra, R.C. Antidepressant-like effect of rosmarinic acid during LPS- induced neuroinflammatory model: The potential role of cannabinoid receptors/PPAR- γ signaling pathway. Phytotherapy Res. 2021, 35, 6974–6989. [Google Scholar] [CrossRef]
  49. Wang, S.; Li, Y.; Meng, X.; Chen, S.; Huang, D.; Xia, Y.; Zhu, S. Antioxidant activities of chlorogenic acid derivatives with different acyl donor chain lengths and their stabilities during in vitro simulated gastrointestinal digestion. Food Chem. 2021, 357, 129904. [Google Scholar] [CrossRef] [PubMed]
  50. Zhang, Y.; Chen, N.; Xin, N.; Li, Q.; Zhang, T.; Ye, H.; Zhao, C. Complexation of chlorogenic acid enhances the antiproliferative effect of lactoferrin to colon cancer cells. Food Biosci. 2022, 46, 101601. [Google Scholar] [CrossRef]
  51. Masoomzadeh, F.; Khan, B.A.; Alshahrani, S.M.; Alqahtani, A.; Ebrahimzadeh, M.A.; Khalili, M. Protective effects of rutin and chlorogenic acid against antihypoxic conditions in mice. Pak. J. Pharm. Sci. 2021, 34, 1679–1683. [Google Scholar]
  52. Vassão, D.G.; Kim, K.-W.; Davin, L.B.; Lewis, N.G. Lignans (neolignans) and allyl/propenyl phenols: Biogenesis, structural biology, and biological/human health considerations. In Natural Products Structural Diversity—I. Secondary Metabolites: Organization and Biosynthesis; Elsevier: Amsterdam, The Netherlands, 2010; Volume 1, pp. 815–928. [Google Scholar]
  53. Waswa, E.N.; Li, J.; Mkala, E.M.; Wanga, V.O.; Mutinda, E.S.; Nanjala, C.; Odago, W.O.; Katumo, D.M.; Gichua, M.K.; Gituru, R.W. Ethnobotany, phytochemistry, pharmacology, and toxicology of the genus Sambucus L. (Viburnaceae). J. Ethnopharmacol. 2022, 292, 115102. [Google Scholar] [CrossRef]
  54. Salehi, B.; Sharifi-Rad, J.; Cappellini, F.; Reiner, Ž.; Zorzan, D.; Imran, M.; Sener, B.; Kilic, M.; El-Shazly, M.; Fahmy, N.M. The therapeutic potential of anthocyanins: Current approaches based on their molecular mechanism of action. Front. Pharmacol. 2020, 11, 1300. [Google Scholar] [CrossRef]
  55. Swinny, E.E.; Bloor, S.J.; Wong, H. H and 13C NMR assignments for the 3-deoxyanthocyanins, luteolinidin-5-glucoside and apigeninidin-5-glucoside. Magn. Reson. Chem. 2000, 38, 1031–1033. [Google Scholar] [CrossRef]
  56. Thurman, E.M. Analysis of Terpenes in Hemp (Cannabis sativa) by Gas Chromatography/Mass Spectrometry: Isomer Identification Analysis. Compr. Anal. Chem. 2020, 90, 197–233. [Google Scholar] [CrossRef]
  57. Krist, S.; Banovac, D.; Tabanca, N.; Wedge, D.E.; Gochev, V.K.; Wanner, J.; Schmidt, E.; Jirovetz, L. Antimicrobial activity of nerolidol and its derivatives against airborne microbes and further biological activities. Nat. Prod. Commun. 2015, 10, 143–148. [Google Scholar] [CrossRef] [PubMed]
  58. Chan, W.-K.; Tan, L.T.-H.; Chan, K.-G.; Lee, L.-H.; Goh, B.-H. Nerolidol: A sesquiterpene alcohol with multi-faceted pharmacological and biological activities. Molecules 2016, 21, 529. [Google Scholar] [CrossRef] [Green Version]
  59. Ferrer, A.; Altabella, T.; Arró, M.; Boronat, A. Emerging roles for conjugated sterols in plants. Prog. Lipid Res. 2017, 67, 27–37. [Google Scholar] [CrossRef] [PubMed]
  60. Arai, H.; Watanabe, B.; Nakagawa, Y.; Miyagawa, H. Synthesis of ponasterone A derivative with various steroid skeleton moieties and evaluation of their binding to the ecdysone receptor of Kc cells. Steroids 2008, 73, 1452–1464. [Google Scholar] [CrossRef] [PubMed]
  61. Burdge, G.C.; Calder, P.C. Introduction to Fatty Acids and Lipids. World Rev. Nutr. Diet. 2015, 112, 1–16. [Google Scholar] [CrossRef]
  62. Karimi, E.; Jaafar, H.Z.E.; Ghasemzadeh, A.; Ebrahimi, M. Fatty acid composition, antioxidant and antibacterial properties of the microwave aqueous extract of three varieties of Labisia pumila Benth. Biol. Res. 2015, 48, 1–6. [Google Scholar] [CrossRef] [Green Version]
  63. Voronkov, A.S.; Ivanova, T. V Fatty Acids Composition of the Epiphytic Ferns, Platycerium bifurcatum and Asplenium nidus, and the Terrestrial Fern, Asplenium trichomanes. Am. Fern J. 2021, 111, 117–128. [Google Scholar] [CrossRef]
  64. Swinny, E.E. A Novel Acetylated 3-Deoxyanthocyanidin Laminaribioside from the Fern. Z. Naturforsch. 2001, 56, 177–180. [Google Scholar] [CrossRef]
  65. Oskoueian, E.; Abdullah, N.; Hendra, R.; Karimi, E. Bioactive Compounds, Antioxidant, Xanthine Oxidase Inhibitory, Tyrosinase Inhibitory and Anti-Inflammatory Activities of Selected Agro-Industrial By-products. Int. J. Mol. Sci. 2011, 12, 8610–8625. [Google Scholar] [CrossRef]
  66. Rahmawati, D.; Rifky, N.A.; Marpaung, A.M. Extraction and stability analysis of antioxidant activity from Stenochlaena palustris. In Proceedings of the International Postgraduate Symposium on Food, Agriculture and Biotechnology Extraction, Maha Sarakham, Thailand, 30–31 August 2017; pp. 45–52. [Google Scholar]
  67. Takuli, P.; Khulbe, K.; Kumar, P.; Parki, A.; Syed, A.; Elgorban, A.M. Phytochemical profiling, antioxidant and antibacterial efficacy of a native Himalayan Fern: Woodwardia unigemmata (Makino) Nakai. Saudi J. Biol. Sci. 2020, 27, 1961–1967. [Google Scholar] [CrossRef]
  68. Halder, K.; Chakraborty, S. An account of antioxidant potential in pteridophytes: A biochemical perspective. Int. J. Bioinform. Biol. Sci. 2018, 6, 15–24. [Google Scholar] [CrossRef]
  69. Lai, H.Y.; Lim, Y.Y.; Tan, S.P. Antioxidative, tyrosinase inhibiting and antibacterial activities of leaf extracts from medicinal ferns. Biosci. Biotechnol. Biochem. 2009, 73, 1362–1366. [Google Scholar] [CrossRef]
  70. Mothana, R.A.; Lindequist, U.; Gruenert, R.; Bednarski, P.J. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra. BMC Complement. Altern. Med. 2009, 9, 1–11. [Google Scholar] [CrossRef] [Green Version]
  71. Grierson, D.S.; Afolayan, A.J. Antibacterial activity of some indigenous plants used for the treatment of wounds in the Eastern Cape, South Africa. J. Ethnopharmacol. 1999, 66, 103–106. [Google Scholar] [CrossRef]
  72. Kaur, G.J.; Arora, D.S. Antibacterial and phytochemical screening of Anethum graveolens, Foeniculum vulgare and Trachyspermum ammi. BMC Complement. Altern. Med. 2009, 9, 30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Ali, N.A.A.; Jülich, W.-D.; Kusnick, C.; Lindequist, U. Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities. J. Ethnopharmacol. 2001, 74, 173–179. [Google Scholar] [CrossRef]
  74. Kelmanson, J.E.; Jäger, A.K.; van Staden, J. Zulu medicinal plants with antibacterial activity. J. Ethnopharmacol. 2000, 69, 241–246. [Google Scholar] [CrossRef]
  75. Medzhitov, R. Origin and physiological roles of inflammation. Nature 2008, 454, 428–435. [Google Scholar] [CrossRef]
  76. Netea, M.G.; Balkwill, F.; Chonchol, M.; Cominelli, F.; Donath, M.Y.; Giamarellos-Bourboulis, E.J.; Golenbock, D.; Gresnigt, M.S.; Heneka, M.T.; Hoffman, H.M.; et al. A guiding map for inflammation. Nat. Immunol. 2017, 18, 826–831. [Google Scholar] [CrossRef] [Green Version]
  77. Gong, T.; Liu, L.; Jiang, W.; Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 2020, 20, 95–112. [Google Scholar] [CrossRef]
  78. Miranda, G.M.; Bessa, J.R.; Teles, Y.C.F.; Cocou, S.; Alexandre, M.; Goncalves, M.S.; Ribeiro-filho, J. Inclusion Complexes of Non-Steroidal Anti-Inflammatory Drugs with Cyclodextrins: A Systematic Review. Biomolecules 2021, 11, 361. [Google Scholar] [CrossRef] [PubMed]
  79. Dogné, J.-M.; Supuran, C.T.; Pratico, D. Adverse cardiovascular effects of the coxibs. J. Med. Chem. 2005, 48, 2251–2257. [Google Scholar] [CrossRef] [PubMed]
  80. Martín Arias, L.H.; Martín González, A.; Sanz Fadrique, R.; Vazquez, E.S. Cardiovascular risk of nonsteroidal anti-inflammatory drugs and classical and selective cyclooxygenase-2 inhibitors: A meta-analysis of observational studies. J. Clin. Pharmacol. 2019, 59, 55–73. [Google Scholar] [CrossRef] [Green Version]
  81. Schäcke, H.; Döcke, W.-D.; Asadullah, K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther. 2002, 96, 23–43. [Google Scholar] [CrossRef]
  82. Fasolo, J.M.M.A.; Fernanda, A.; Vizuete, K.; Rico, E.P.; Rambo, R.B.S.; Toson, N.S.B.; Santos, E.; De Oliveira, D.L.; Gonçalves, C.A.S.; Schapoval, E.E.S.; et al. Comparative Biochemistry and Physiology, Part C Anti-inflammatory effect of rosmarinic acid isolated from Blechnum brasiliense in adult zebrafish brain. Comp. Biochem. Physiol. Part C 2021, 239, 108874. [Google Scholar] [CrossRef]
  83. Bray, F.; Laversanne, M.; Weiderpass, E.; Soerjomataram, I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 2021, 127, 3029–3030. [Google Scholar] [CrossRef]
  84. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef]
  85. Tyavambiza, C.; Dube, P.; Goboza, M.; Meyer, S.; Madiehe, A.M.; Meyer, M. Wound Healing Activities and Potential of Selected African Medicinal Plants and Their Synthesized Biogenic Nanoparticles. Plants 2021, 10, 2635. [Google Scholar] [CrossRef]
  86. Akkol, E.K.; Koca, U.; Peşin, I.; Yılmazer, D.; Toker, G.; Yeşilada, E. Exploring the wound healing activity of Arnebia densiflora (Nordm.) Ledeb. by in vivo models. J. Ethnopharmacol. 2009, 124, 137–141. [Google Scholar] [CrossRef]
  87. Demilew, W.; Adinew, G.M.; Asrade, S. Evaluation of the wound healing activity of the crude extract of leaves of Acanthus polystachyus Delile (Acanthaceae). Evid.-Based Complement. Altern. Med. 2018, 2018, 2047896. [Google Scholar] [CrossRef] [Green Version]
  88. Arnason, J.T.; Philogene, B.J.R.; Morand, P. Insecticides of Plant Origin; American Chemistry Society: Washington, DC, USA, 1989. [Google Scholar]
  89. Mordue, A.J. Azadirachtin—A review of its mode of action in insects. In Practice Oriented Results on Use and Production of Neem-Ingredients and Pheromones; Duck&Graphic: Giessen, Germany, 1998; pp. 1–4. [Google Scholar]
  90. Pardede, A.; Adfa, M.; Kusnanda, A.J.; Ninomiya, M.; Koketsu, M. Isolation of secondary metabolites from Stenochlaena palustris stems and structure-activity relationships of 20-hydroxyecdysone derivatives on antitermite activity. Holzforschung 2018, 72, 899–904. [Google Scholar] [CrossRef]
  91. Arnault, C.; Sláma, K. Dietary effects of phytoecdysones in the leek-moth, Acrolepiopsis assectella Zell. (Lepidoptera: Acrolepiidae). J. Chem. Ecol. 1986, 12, 1979–1986. [Google Scholar] [CrossRef] [PubMed]
  92. De-Fu, C.; Ming-Xue, S.; Wen-Fu, X. Pesticidal character of phytoecdysteroids from Ajuga multiflora Bunge (Labiatae) on larvae of Cryptorrhynchus lapathi L. (Coleoptera: Curculionidae). J. For. Res. 2002, 13, 177–182. [Google Scholar] [CrossRef]
  93. Descoins, C., Jr. Perception de substances antiappétentes par des chenilles de lépidoptères phytophages. L’Année Biol. 2001, 40, 55–73. [Google Scholar] [CrossRef]
  94. Kalpana Devi, R.; Vasantha, S.; Panneerselvam, A.; Rajesh, N.V.; Jeyathilakan, N.; Venkataramanan, R. Gastrothylax crumenifer: Ultrastructure and histopathology study of in vitro trematodicidal effect of Microlepia speluncae (L.) Moore. J. Appl. Anim. Res. 2017, 46, 427–434. [Google Scholar] [CrossRef] [Green Version]
  95. Singh, T.U.; Kumar, D.; Tandan, S.K. Paralytic effect of alcoholic extract of Allium sativum and Piper longum on liver amphistome, Gigantocotyle explanatum. Indian J. Pharmacol. 2008, 40, 64. [Google Scholar]
  96. Chai, T.; Yeoh, L.; Ismaliza, N.; Ismail, M.; Manan, F.A.; Wong, F. Evaluation of Glucosidase Inhibitory and Cytotoxic Potential of Five Selected Edible and Medicinal Ferns. Trop. J. Pharm. Res. 2015, 14, 449–454. [Google Scholar] [CrossRef] [Green Version]
Figure 1. (a) Mid-green glossy fronds of Blechnum, (b) Oblong leaflets, (c) Leaves with sporangia at the adaxial surface, (d) Pinnate sterile/fertile fronds.
Figure 1. (a) Mid-green glossy fronds of Blechnum, (b) Oblong leaflets, (c) Leaves with sporangia at the adaxial surface, (d) Pinnate sterile/fertile fronds.
Pharmaceuticals 15 00905 g001
Figure 2. Distribution of Blechnum species (GBIF).
Figure 2. Distribution of Blechnum species (GBIF).
Pharmaceuticals 15 00905 g002
Figure 3. Traditional herbal uses of Blechnum species.
Figure 3. Traditional herbal uses of Blechnum species.
Pharmaceuticals 15 00905 g003
Figure 4. Application of Blechnum species against different ailments.
Figure 4. Application of Blechnum species against different ailments.
Pharmaceuticals 15 00905 g004
Figure 5. Chemical compounds isolated from Blechnum species.
Figure 5. Chemical compounds isolated from Blechnum species.
Pharmaceuticals 15 00905 g005
Figure 6. Chemical structures of some phenolic compounds isolated from Blechnum species.
Figure 6. Chemical structures of some phenolic compounds isolated from Blechnum species.
Pharmaceuticals 15 00905 g006
Figure 7. Chemical structures of terpenoids isolated from Blechnum species.
Figure 7. Chemical structures of terpenoids isolated from Blechnum species.
Pharmaceuticals 15 00905 g007
Figure 8. Chemical structures of sterols isolated from Blechnum species.
Figure 8. Chemical structures of sterols isolated from Blechnum species.
Pharmaceuticals 15 00905 g008
Figure 9. Representative chemical structures of fatty acids isolated from Blechnum species.
Figure 9. Representative chemical structures of fatty acids isolated from Blechnum species.
Pharmaceuticals 15 00905 g009
Figure 10. Chemical structures of alcohols, aldehydes and carotenoids from Blechnum species.
Figure 10. Chemical structures of alcohols, aldehydes and carotenoids from Blechnum species.
Pharmaceuticals 15 00905 g010
Figure 11. Types of Blechnum species with biological properties.
Figure 11. Types of Blechnum species with biological properties.
Pharmaceuticals 15 00905 g011
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Waswa, E.N.; Muema, F.W.; Odago, W.O.; Mutinda, E.S.; Nanjala, C.; Mkala, E.M.; Amenu, S.G.; Ding, S.-X.; Li, J.; Hu, G.-W. Traditional Uses, Phytochemistry, and Pharmacological Properties of the Genus Blechnum—A Narrative Review. Pharmaceuticals 2022, 15, 905. https://doi.org/10.3390/ph15070905

AMA Style

Waswa EN, Muema FW, Odago WO, Mutinda ES, Nanjala C, Mkala EM, Amenu SG, Ding S-X, Li J, Hu G-W. Traditional Uses, Phytochemistry, and Pharmacological Properties of the Genus Blechnum—A Narrative Review. Pharmaceuticals. 2022; 15(7):905. https://doi.org/10.3390/ph15070905

Chicago/Turabian Style

Waswa, Emmanuel Nyongesa, Felix Wambua Muema, Wyclif Ochieng Odago, Elizabeth Syowai Mutinda, Consolata Nanjala, Elijah Mbandi Mkala, Sarah Getachew Amenu, Shi-Xiong Ding, Jing Li, and Guang-Wan Hu. 2022. "Traditional Uses, Phytochemistry, and Pharmacological Properties of the Genus Blechnum—A Narrative Review" Pharmaceuticals 15, no. 7: 905. https://doi.org/10.3390/ph15070905

APA Style

Waswa, E. N., Muema, F. W., Odago, W. O., Mutinda, E. S., Nanjala, C., Mkala, E. M., Amenu, S. G., Ding, S. -X., Li, J., & Hu, G. -W. (2022). Traditional Uses, Phytochemistry, and Pharmacological Properties of the Genus Blechnum—A Narrative Review. Pharmaceuticals, 15(7), 905. https://doi.org/10.3390/ph15070905

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop